Booking Holdings Inc. (BKNG): Stephen Mandel Trims Position
We just covered Lone Pine’s Non-AI Strategy Falters: 10 Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns and Booking Holdings Inc.
Insider Monkey Blog
Spotify Technology S.A. (SPOT): Stephen Mandel Likes This Streaming Company
We just covered Lone Pine’s Non-AI Strategy Falters: 10 Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns and Spotify Technology S.A.
TransDigm Group Incorporated (TDG): Stephen Mandel Continues Bullish Stance
We just covered Lone Pine’s Non-AI Strategy Falters: 10 Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns and TransDigm Group Incorporated (NYSE:TDG) ranks 7th on ...
Visa Inc. (V): Stephen Mandel Likes This Payments Company
Visa Inc. (NYSE:V) has been a staple in the 13F portfolio of Lone Pine Capital. The fund first disclosed a stake in the company back in the third quarter of 2011.
LPL Financial Holdings Inc. (LPLA): Stephen Mandel Trims Holding
We just covered Lone Pine’s Non-AI Strategy Falters: 10 Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns and LPL Financial Holdings Inc.
Carvana Co. (CVNA): Stephen Mandel Is Bullish on This Stock
Carvana Co. (NYSE:CVNA) is a long-term holding in the 13F portfolio of Lone Pine Capital. The fund first disclosed a stake in the company back in the fourth quarter of 2019.
Centene Corporation (CNC): David Einhorn Is Bullish on This Managed Care Firm
Centene Corporation (NYSE:CNC) recently posted Q1 2026 results that significantly cleared the high bar set by institutional expectations.
Teva Pharmaceutical (TEVA): David Einhorn Likes This Pharma Stock
Institutional sentiment towards Teva Pharmaceutical Industries Limited (NYSE:TEVA) has shifted significantly following Q4 2025 earnings, which many funds used as a signal to accumulate...
Victoria’s Secret & Co. (VSCO): Under-the-Radar Pick from David Einhorn Is Dominating 2026
Victoria’s Secret & Co. (NYSE:VSCO) first appeared in the 13F portfolio of Greenlight Capital in the third quarter of 2023.
DHT Holdings Inc. (DHT): One the Premier Under-the-Radar Picks from David Einhorn
DHT Holdings, Inc. (NYSE:DHT) has been a consistent feature in the 13F portfolio of Greenlight Capital since the third quarter of 2023.
Acadia Healthcare Company Inc. (ACHC): One of the Best Under-the-Radar Picks from David Einhorn
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) is a relatively recent addition to the 13F portfolio of Greenlight Capital.
ZenaTech Reports Record 558% Year-Over-Year Revenue Growth to $12.9 Million for Full Year 2025 as Drone as a Service Business Expansion Accelerates and Q4 Revenue increases 670%
VANCOUVER, British Columbia, April 29, 2026 — ZenaTech, Inc.
BKV Corporation (BKV): David Einhorn Is Buying This Gas Stock
BKV Corporation (NYSE:BKV) is a new addition to the 13F portfolio of Greenlight Capital.
Slide Insurance Holdings Inc. (SLDE): David Einhorn Opens New Position
Slide Insurance Holdings, Inc. (NASDAQ:SLDE) is a new addition to the 13F portfolio of Greenlight Capital.
TD SYNNEX Corporation (SNX): David Einhorn Is Buying This Stock
TD SYNNEX Corporation (NYSE:SNX) first appeared in the 13F portfolio of Greenlight Capital in the third quarter of 2020.
Procter & Gamble (PG): The Best Consumer Staples Stock to Invest In
On April 27, 2026, UBS raised its price target on The Procter & Gamble Company (NYSE:PG) to $172 from $166 and maintained a Buy rating.
Stifel Maintains Buy Rating on Monster Beverage (MNST)
On April 20, 2026, TD Cowen lowered its price target on Monster Beverage Corporation (NASDAQ:MNST) to $80 from $88 and maintained a Hold rating.
TD Cowen Maintains Buy Rating on e.l.f. Beauty (ELF)
On April 23, 2026, TD Cowen lowered its price target on e.l.f. Beauty, Inc.
Morgan Stanley Maintains Equal Weight Rating on J. M. Smucker (SJM)
On April 23, 2026, Morgan Stanley lowered its price target on The J. M. Smucker Company (NYSE:SJM) to $104 from $118 and maintained an Equal Weight rating.
BJ’s Wholesale Club (BJ) Expands into Texas
On April 17, 2026, BJ’s Wholesale Club Holdings, Inc. (NYSE:BJ) announced its expansion into Texas, with the grand opening of its Forney location scheduled for April 24.
Is Keurig Dr Pepper (KDP) the Best Consumer Staples Stock to Invest In?
On April 27, 2026, Barclays raised its price target on Keurig Dr Pepper Inc. (NASDAQ:KDP) to $30 from $28 and maintained an Equal Weight rating.
JPMorgan Raises its Price Target on JBS N.V. (JBS) to $20.50
On April 24, 2026, JPMorgan analyst Lucas Ferreira raised the price target on JBS N.V.
JPMorgan Maintains Neutral Rating on Church & Dwight (CHD)
On April 17, 2026, JPMorgan lowered its price target on Church & Dwight Co., Inc.
TD Cowen Maintains Hold Rating on Estée Lauder (EL)
On April 23, 2026, TD Cowen lowered its price target on The Estée Lauder Companies Inc.
BofA Maintains Buy Rating on Sysco (SYY)
On April 24, 2026, BofA lowered its price target on Sysco Corporation (NYSE:SYY) to $91 from $102 previously and maintained a Buy rating on the shares as part of a broader update...
Erste Group Downgrades Kroger (KR) to Hold
On April 27, 2026, Erste Group downgraded The Kroger Co.
How Traders Should Approach Social Casinos
Knowing what a business really sells usually clears up half the argument.
KKR & Co. (KKR) Falls on Earnings Miss Despite Strong Fundraising Momentum and Long-Term Growth Plans
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund" Q1 2026 Investor Letter. A copy of the letter can be downloaded here.
Corcept Therapeutics (CORT) Inspires Confidence with ROSELLA Phase 3 Survival Data
On April 11, Corcept Therapeutics Inc.
Beam Therapeutics (BEAM) Reveals Encouraging Results From Risto-Cel Phase 1/2 BEACON Study
On April 2, Beam Therapeutics Inc. (NASDAQ:BEAM) released results from its Phase 1/2 BEACON study for ristoglogene autogetemcel.
Optimism Surrounds Praxis Precision Medicines (PRAX) Amid Potential FDA Approval for Ulixacaltamide
As of the close of play on April 24, the broader consensus sentiments towards Praxis Precision Medicines Inc. (NASDAQ:PRAX) remained strongly bullish.
What Makes Denali Therapeutics (DNLI) One of the Best Biotech Stocks to Invest in
On April 6, Denali Therapeutics Inc.
Ultragenyx Pharmaceutical (RARE) Garnering Bullish Sentiment With Forthcoming GTX-102 Phase 3 Angelman Trial
On April 16, Morgan Stanley increased the price target for Ultragenyx Pharmaceutical Inc.
H.C. Wainwright Reaffirms Buy Rating for Legend Biotech (LEGN)
On April 20, H.C. Wainwright maintained its Buy rating for Legend Biotech Corp. (NASDAQ:LEGN).
Crinetics Pharmaceuticals (CRNX) is One of the Best Biotech Stocks to Buy, Here is Why
As of the April 24 closing, the stock carries a strongly bullish consensus sentiment. With a price target of $86.71, it yields more than 126% upside potential.
Ocular Therapeutix Inc. (OCUL) Appears Highly Attractive Following SOL-1 Clinical Trial Data
On April 13, William Blair maintained an Outperform rating on Ocular Therapeutix (NASDAQ:OCUL) right after the presentation of additional SOL-1 clinical trial data.
Here is Why Structure Therapeutics (GPCR) is One of the Top Biotech Names to Look at
As of April 24 closing, the stock carries a strongly bullish consensus sentiment, receiving Buy ratings from all 14 analysts.
What is Driving a Strong Bullish Sentiment Towards Viking Therapeutics (VKTX)
Back on March 26, Viking Therapeutics Inc.
Sizzling Returns: 7 Energy Stocks That Just Hit New All-Time Highs
As of the writing of this piece, the S&P Energy index has surged by 25.73% since the beginning of 2026.
Do You Believe in The Long-Term Growth Outlook of Thermo Fisher Scientific (TMO)?
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here...
Sizzling Returns: 5 Energy Stocks That Just Hit New All-Time Highs
In this article, we will take a look at the 5 Energy Stocks That Just Hit New All-Time Highs.
How the Gambling Market Is Expanding in Regulated and Emerging Markets?
The global gambling market has experienced steady growth over the past ten years, largely due to the shift to online platforms and mobile access.
Eli Lilly and Company (LLY) Declined in Q1 Despite Strong Results
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here...
7 Best Data Center Hardware Stocks to Invest in
On April 23, Reuters reported that Nokia CEO Justin Hotard cautioned that Europe risks slipping behind the United States and China in AI data center investment because of infrastructural...
5 Best Data Center Hardware Stocks to Invest in
In this article, we will take a look at the 5 Best Data Center Hardware Stocks to Invest in.
Should You Be Bullish on Natera (NTRA)?
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here...
Baron Health Care Fund’s Q1 2026 Investor Letter
Baron Capital, an investment management company, released its Q1 2026 investor letter for the “Baron Health Care Fund”.
Here’s Why Polen Focus Growth Exited Abbott Laboratories (ABT) in Q1
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here...
What Makes Rollins (ROL) an Attractive Investment?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here...
Polen Focus Growth Bets on Lam Research (LRCX), a Critical Supplier of Etch and Deposition Equipment
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here...
Hedge Fund Resource Center
